Anzeige
Mehr »
Samstag, 27.06.2026 - Börsentäglich über 12.000 News
Tagebau oder Tiefsee-Bergbau: Für welchen Fußabdruck entscheidet sich die Welt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EDH3 | ISIN: US04537Y2081 | Ticker-Symbol: N/A
1-Jahres-Chart
ASPIRA WOMENS HEALTH INC Chart 1 Jahr
5-Tage-Chart
ASPIRA WOMENS HEALTH INC 5-Tage-Chart

Aktuelle News zur ASPIRA WOMENS HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ASPIRA WOMENS HEALTH Aktie jetzt für 0€ handeln
17.06.Aspira Women's Health Inc. - 8-K, Current Report1
09.06.Aspira Women's Health Inc. - 8-K, Current Report1
26.05.Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health1.599Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation AUSTIN, TX AND CLEVELAND, OH / ACCESS Newswire / May 26...
► Artikel lesen
26.05.Aspira Women's Health Inc. - 8-K, Current Report2
23.04.Aspira Women's Health Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform195AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease...
► Artikel lesen
01.04.Aspira Women's Health Inc. - 10-K, Annual Report-
01.04.Aspira Women's Health Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405-
30.01.Aspira Women's Health Inc. - 8-K, Current Report3
31.12.25Aspira Women's Health Inc. - S-1, General form for registration of securities-
31.12.25Aspira Women's Health Inc. - 8-K, Current Report-
14.11.25Aspira Women's Health: Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update893AUSTIN, TX / ACCESS Newswire / November 14, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQX:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive...
► Artikel lesen
29.10.25Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston422Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women's Health Inc., abio-analytical-based...
► Artikel lesen
18.09.25Aspira Women's Health Announces Equity Capital Infusion of $3.06 Million in Private Placement and Warrant Exercise456$2.95 Million PIPE$112 thousand warrant exercise AUSTIN, TX / ACCESS Newswire / September 18, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health...
► Artikel lesen
04.09.25Aspira Women's Health Appoints New Chief Financial Officer342New Executive Brings 20+ Years of Accounting,Capital Markets & Biotechnology Experience AUSTIN, TX / ACCESS Newswire / September 4, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQB:AWHL)...
► Artikel lesen
13.08.25Aspira Women's Health: Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update524AUSTIN, TX / ACCESS Newswire / August 13, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive...
► Artikel lesen
15.07.25Aspira Women's Health Announces Appointment of Jane Pine Wood to the Board of Directors463AUSTIN, TX / ACCESS Newswire / July 15, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQB:AWHL), an AI enhanced bio-analytical based women's health company focused on delivering the...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1